Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 0 | 25 | 0 | 0 | 0 |
| Gross Profit | N/A | 25 | N/A | N/A | N/A |
| Operating Expenses | 3,116 | 2,359 | 2,585 | 3,374 | 3,694 |
| Operating Income | -3,116 | -2,334 | -2,585 | -3,374 | -3,694 |
| Interest Expense | 12 | 13 | 13 | 11 | 7 |
| Other Income | 42 | 73 | 88 | 115 | 157 |
| Pre-tax Income | -3,086 | -2,274 | -2,510 | -3,270 | -3,544 |
| Net Income Continuous | -3,086 | -2,274 | -2,409 | -3,270 | -3,544 |
| Net Income | $-3,086 | $-2,274 | $-2,409 | $-3,270 | $-3,544 |
| EPS Basic Total Ops | -8,705.91 | -6,727.29 | -7,123.02 | -9,497.35 | -10,288.80 |
| EPS Basic Continuous Ops | -8,887.86 | -6,570.87 | -7,002.21 | -9,470.63 | -10,273.58 |
| EPS Diluted Total Ops | -8,705.91 | -6,727.29 | -7,123.02 | -9,497.35 | -10,288.80 |
| EPS Diluted Continuous Ops | -8,887.86 | -6,570.87 | -7,002.21 | -9,470.63 | -10,273.58 |
| EBITDA(a) | $-3,021 | $-2,234 | $-2,473 | $-3,212 | $-3,553 |